|
Press Releases |
|
![](/images/company/Lexaria.jpg) |
|
Tuesday, July 16, 2024 |
|
Lexaria Preparing For Strategic Growth |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces plans for strategic growth. more info >> |
|
Monday, July 8, 2024 |
|
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces three new patent awards. more info >> |
|
Wednesday, May 8, 2024 |
|
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that human pilot study #2, GLP-1-H24-2, (the "Study") is underway and the first dosing visit for all nine study participants has already concluded. more info >> |
|
Monday, May 6, 2024 |
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs |
Lexaria Bioscience Corp. (Nasdaq: LEXX & LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 ("GLP-1") drug, semaglutide, related to its mode of action and performance. more info >> |
|
Tuesday, April 16, 2024 |
|
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces approval has been received from an independent third-party ethics review board, for human pilot study #2 (the "Study"), investigating GLP-1 drugs and DehydraTECH. more info >> |
|
Tuesday, April 2, 2024 |
|
Lexaria Awarded New Patents |
more info >> |
|
Thursday, March 14, 2024 |
|
Lexaria Appoints Nelson Cabatuan as Chief Financial Officer |
Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces the appointment of Nelson Cabatuan, CPA, as Chief Financial Officer (CFO) effective immediately. more info >> |
|
Thursday, March 7, 2024 |
|
Lexaria Awards Contract For Next GLP-1 Human Pilot Study |
Lexaria Bioscience Corp. (Nasdaq: LEXX) (Nasdaq: LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces it has hired a contract research organization ("CRO") to perform the Company's second DehydraTECH-powered glucagon-like peptide 1 ("GLP-1") human pilot study #2 (the "Study"). more info >> |
|
Tuesday, March 5, 2024 |
|
Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 |
more info >> |
|
Monday, March 4, 2024 |
|
7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study |
more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Best BLUETTI Prime Day Deals on Portable Power Stations and Solar Generators
Jul 16, 2024 22:00 HKT/SGT
|
|
|
Lexaria Preparing For Strategic Growth
Jul 16, 2024 21:20 HKT/SGT
|
|
|
'Alamein Festival' Launches Exciting Second Edition for 2024
Jul 16, 2024 21:00 HKT/SGT
|
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 21:00: JST
|
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT/SGT
|
|
|
How Artificial Intelligence Can Help Give Your Business a Boost
Jul 16, 2024 19:30 HKT/SGT
|
|
|
U.S. Polo Assn. Proudly Partners with the 2024 Outsourcing Inc. Royal Charity Polo Cup
Jul 16, 2024 19:00 HKT/SGT
|
|
|
Neste and Mitsubishi Corporation agree on strategic partnership to develop supply chains for renewable chemicals and plastics
Jul 16, 2024 18:36 JST
|
|
|
NEC technology reliably measures sea levels from a greater distance
Jul 16, 2024 17:45 JST
|
|
|
全球发展数字经济直播访谈会正式举办 外方来华参会高级别代表走进东方甄选直播间
Jul 16, 2024 15:08 HKT/SGT
|
|
|
巨星傳奇(6683.HK)解禁後首個交易日 收盤報10.4港元 升幅達2.97%
Jul 16, 2024 15:04 HKT/SGT
|
|
|
巨星传奇(6683.HK)解禁后首个交易日: 收盘报10.4港元 升幅达2.97%
Jul 16, 2024 14:58 HKT/SGT
|
|
|
全球發展數字經濟直播訪談會正式舉辦 外方來華參會高級別代表走進東方甄選直播間
Jul 16, 2024 14:25 HKT/SGT
|
|
|
Fujitsu and Cohere launch strategic partnership and joint development to provide generative AI for enterprises
Jul 16, 2024 15:13 JST
|
|
|
Komisi Penerbangan Malaysia Memilih TransNusa Sebagai Salah Satu Dari Dua Maskapai Asing Untuk Meluncurkan Penerbangan Dari Bandara Subang
Jul 16, 2024 14:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|